A commercial-stage biopharmaceutical company marketing two FDA-approved products with its national primary care sales force, a cardiovascular product, ANTARA(r) capsules and a fluoroquinolone antibiotic, FACTIVE(r) tablets.
The best Bull and Bear pitches based on recency and number of recommendations.
Stock dumped yesterday when company's release of financial statements reminded the market that Company projections do not meet analyst projections. HOWEVER, OSCI's guidance is very positive and enticing to this fool. (see official guidance below).… More
There are no pitches that meet the Top Bear criteria. Explain
If this upsets you, start recommending pitches below!
Read the most recent pitches from players about OSCIQ.
Find the members with the highest scoring picks in OSCIQ.
OverAnalyze (32.92) Score: +375.96
The Score Leader is the player with the highest score across all their picks in OSCIQ.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
OverAnalyze | 32.92 | 4/17/2007 | 5Y | $7.70 | -99.88% | +276.09% | +375.96 | 0 Comment | ||
BasketQase | 84.92 | 12/29/2006 | 1Y | $5.07 | -99.81% | +291.41% | -391.23 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.